RecruitingNCT06174506

The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers


Sponsor

University of Medicine and Pharmacy at Ho Chi Minh City

Enrollment

300 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether two blood markers — high-sensitivity troponin I (a heart stress marker) and NT-proBNP (a heart failure marker) — can predict which patients undergoing lung surgery will develop an irregular heartbeat called atrial fibrillation afterward, which is a common and serious complication. **You may be eligible if...** - You are an adult scheduled for lung surgery (such as for lung cancer) - You do not already have a diagnosis of atrial fibrillation - You are willing to have blood tests before surgery and be monitored after **You may NOT be eligible if...** - You already have atrial fibrillation or significant heart arrhythmias - You have end-stage kidney disease or other conditions that significantly affect these biomarker levels - You are unable to consent to participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Cho Ray Hospital

Ho Chi Minh City, None Selected, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06174506


Related Trials